Digital-supported Orofacial Myofunctional Therapy in OSA
1 other identifier
interventional
60
1 country
1
Brief Summary
This pilot study explores the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative program combining facial recognition technology with evidence-based orofacial exercises for individuals with mild to moderate obstructive sleep apnoea (OSA). The d-MFT program aims to strengthen oropharyngeal muscles, improve airway function, and reduce OSA severity. Participants receiving 3-month d-MFT (n=30) are expected to demonstrate greater improvements in OSA severity, sleep-related symptoms, and quality of life compared to those in the waitlist control group (n=30). Feasibility and acceptability will be evaluated through outcome-based questionnaires and semi-structured interviews to explore participants' experiences, satisfaction, and perceived barriers to adherence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2025
CompletedFirst Posted
Study publicly available on registry
December 18, 2025
CompletedStudy Start
First participant enrolled
January 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
March 13, 2026
March 1, 2026
1.1 years
December 6, 2025
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Programme satisfaction
measured by outcome-based questions with a 5-point Likert scale (ranging from 1 to 5 points). Higher scores indicate higher satisfaction.
month 3
Change in oxygen saturation
Measured by sleep test
Baseline and month 3
Secondary Outcomes (5)
Change in respiratory Indices
Baseline, month 3
Change in snoring
Baseline, month 3
Change in sleep quality
Baseline, month 3
Change in daily function
Baseline, month 3
Change in oropharyngeal muscle function
Baseline, month 3
Study Arms (2)
Waitlist Control Group
NO INTERVENTIONThe waitlist control group will not receive any intervention within the study period
d-MFT Intervention Group
EXPERIMENTALThe d-MFT intervention group will participate in a 3-month digital-support Myofunctional Therapy program. This innovative program is designed to ensure proper exercise performance, enhance adherence, and provide real-time feedback to patients.
Interventions
The intervention include: (1) Five 30-minute d-MFT sessions; (2) two follow-up phone calls; and (3) facial and tongue exercise app for home practice.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years and above
- Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as: Apnoea-Hypopnea Index of 5-30 events per hour
- Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments
- Body Mass Index less than 30 kg/m2
You may not qualify if:
- Presence of obstructive nasal disease or significant nasal obstruction
- Unstable mental health issues
- History of stroke
- Unstable chronic respiratory, cardiac, neurological conditions
- Inability to provide informed consent
- Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hong Kong Metropolitan Universitylead
- Queen Mary Hospital, Hong Kongcollaborator
Study Sites (1)
Queen Mary Hopsital
Hong Kong, Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnes YK Lai, PhD
Hong Kong Metropolitan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 6, 2025
First Posted
December 18, 2025
Study Start
January 5, 2026
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
It has not been mentioned during the IRB application.